Baxter International Inc. will significantly broaden its dialysis product offerings through its acquisition of privately held Gambro AB for $4 billion, the diversified medical products firm announced Dec. 4.
Based in Lund, Sweden, Gambro is a global provider of devices for hemodialysis and continuous renal replacement therapy for both chronic and acute care in institutional settings. The firm generated...